XML 68 R47.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Asset Impairments (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013
Goodwill and Intangible Asset Impairment |  | $ 207,672 |  |
Share Price |  | $ 17.96 | $ 34.20 | $ 95.64
Impairment of Intangible Assets, Finite-lived |  | $ 38,083 |  |
Impairment of Long-Lived Assets Held-for-use |  | 9,361 |  |
Asset impairments |  | 253,560 | $ 0 | $ 0
Asset Impairments Charges and Other PP&E Impairment |  | 255,116 | $ 0 | $ 0
Energy & Chemicals [Member] |  |  |  |
Goodwill and Intangible Asset Impairment |  | 65,023 |  |
Impairment of Intangible Assets, Finite-lived |  | 0 |  |
Impairment of Long-Lived Assets Held-for-use |  | 3,773 |  |
Asset Impairments Charges and Other PP&E Impairment |  | 68,796 |  |
Distribution & Storage [Member] |  |  |  |
Goodwill and Intangible Asset Impairment |  | 316 |  |
Impairment of Intangible Assets, Finite-lived |  | 0 |  |
Impairment of Long-Lived Assets Held-for-use | [1] | 1,704 |  |
Asset Impairments Charges and Other PP&E Impairment |  | 2,020 |  |
BioMedical [Member] |  |  |  |
Goodwill and Intangible Asset Impairment |  | 142,333 |  |
Impairment of Intangible Assets, Finite-lived |  | 38,083 |  |
Impairment of Long-Lived Assets Held-for-use |  | 3,884 |  |
Asset Impairments Charges and Other PP&E Impairment |  | 184,300 |  |
Energy & Chemical and BioMedical [Member] |  |  |  |
Impairment of Long-Lived Assets Held-for-use |  | 7,657 |  |
Customer Relationships [Member] |  |  |  |
Impairment of Intangible Assets, Finite-lived |  | 15,667 |  |
Unpatented Technology [Member] |  |  |  |
Impairment of Intangible Assets, Finite-lived |  | 22,417 |  |
Cost of Sales [Member] |  |  |  |
Asset impairments |  | $ 1,556 |  |
[1] | Asset impairments of $1,556 were included in cost of sales on the consolidated statement of operations for the year ended December 31, 2015.

X
- Definition Asset Impairments Charges and Other PP&E Impairment + References No definition available. + Details
Name: | gtls_AssetImpairmentsChargesandOtherPPEImpairment
Namespace Prefix: | gtls_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2420-110228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 + Details
Name: | us-gaap_AssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill. + References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetImpairment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 225 -Section 45 -Paragraph 11 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=51659069&loc=d3e92212-112881 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Impairment -URI http://asc.fasb.org/extlink&oid=6515133 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2921-110230 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2420-110228 + Details
Name: | us-gaap_ImpairmentOfLongLivedAssetsHeldForUse
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_EnergyChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_DistributionStorageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_BiomedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=gtls_EnergyChemicalandBioMedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |